JACK W SCHULER
CIK 1021412 · Chairman · last filed 2026-08-13
JACK W SCHULER is a Chairman who has filed 411 SEC Form 4 insider transactions across 20 companies since 2007. The most recent filing shows the insider bought $367.0K of BDSX on Aug 13, 2026. Across all open-market trades the lifetime net is +$217.8M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $137.9M across reported positions. 47 SEC filings were submitted jointly with MEDTRONIC INC.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$137.88M
20
411
$217.79M
Filer Profile
LAKE BLUFF, IL 60044
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| BDSX | Director | 555,810 | $29.10 | $16.17M | $51.95M | 47 | 2026-08-13 |
| Aspira Women's Health Inc. (AWH) Delisted | 10%+ Owner | 1,918,692 | $0.08 | $157.3K | $8.50M | 6 | 2025-03-10 |
| Accelerate Diagnostics, Inc (AXDX) Delisted | Director | 25,722 | $0.03 | $875 | $137.68M | 186 | 2024-12-03 |
| YIELD10 BIOSCIENCE, INC. (YTEN) Delisted | 10%+ Owner | 65,290 | $0.35 | $22.9K | $8.88M | 13 | 2023-12-20 |
| SOLENO THERAPEUTICS INC (SLNO) Delisted | 10%+ Owner | 46,595 | $53.01 | $2.47M | $13.02M | 9 | 2023-05-15 |
| Aspira Women's Health Inc. (VRML) Delisted | 10%+ Owner | 29,781,831 | — | — | $11.71M | 15 | 2020-06-11 |
| QDEL | Director | 6,517,302 | $10.94 | $71.30M | $8.04M | 34 | 2020-05-18 |
| BIOLASE, INC (BIOL) Delisted | 10%+ Owner | 296 | $0.02 | $5 | $2.31M | 8 | 2020-05-15 |
| SOLENO THERAPEUTICS INC (SLNOW) Delisted | 10%+ Owner | 4,550,678 | — | — | $4.87M | 1 | 2018-12-26 |
| STERICYCLE INC (SRCLP) Delisted | Director | 655,482 | — | — | $625.9K | 7 | 2018-05-02 |
| STERICYCLE INC (SRCL) Delisted | Director | 700,528 | $61.98 | $43.42M | -$71.69M | 29 | 2016-05-27 |
| STERICYCLE INC (SRCL.P) Delisted | Director | 654,738 | — | — | $0 | 1 | 2015-12-23 |
| Neos Therapeutics, Inc. (NEOS) Delisted | 10%+ Owner | 1,541,149 | $1.15 | $1.77M | $300.0K | 1 | 2015-07-28 |
| YIELD10 BIOSCIENCE, INC. (MBLX) Delisted | 10%+ Owner | 2,185,652 | — | — | $5.53M | 1 | 2015-06-23 |
| HANSEN MEDICAL INC (HNSN) Delisted | Director | 1,855,341 | — | — | $0 | 3 | 2015-06-15 |
| Oncternal Therapeutics, Inc. (GTXI) Delisted | Director | 99,155 | — | — | $12.21M | 8 | 2014-03-21 |
| MDT | Director | 568,617 | $88.64 | $50.40M | $21.27M | 31 | 2013-06-27 |
| Transition Therapeutics Inc. (TTHI) Delisted | 10%+ Owner | 2,823,010 | — | — | $2.60M | 1 | 2011-11-23 |
| VENTANA MEDICAL SYSTEMS INC (VMSI) Delisted | Director | 0 | — | — | $0 | 5 | 2008-02-20 |
| ICOS CORP (ICOS) Delisted | Director | 0 | — | — | $0 | 1 | 2007-01-30 |
Recent Filings
411 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-08-13 | BDSX | Buy (P) | +15,000 | $367.0K | EDGAR |
| 2026-08-12 | BDSX | Buy (P) | +27,600 | $665.9K | EDGAR |
| 2026-06-09 | — | Buy (P) | +222,222 | $100.0K | |
| 2026-01-27 | BDSX | Buy (P) | +100,000 | $1.18M | EDGAR |
| 2026-01-26 | BDSX | Buy (P) | +82,465 | $903.6K | EDGAR |
| 2025-09-23 | BDSX | Buy (P) | +142,045 | $1000.0K | EDGAR |
| 2025-09-19 | — | Buy (P) | +1,111,111 | $500.0K | |
| 2025-09-19 | BDSX | Buy (P) | +18,373 | $111.4K | EDGAR |
| 2025-09-03 | BDSX | Buy (P) | +3,488,372 | $1.50M | EDGAR |
| 2025-05-20 | BDSX | Buy (P) | +4,723,239 | $1.32M | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.